TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
PLRX

Pliant Therapeutics Inc

Healthcare · Biotechnology

1.10$ -1.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PLRX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +915.2% +79.0% +148.2% -25.1% +58.5% +46.1% -22.5% -43.3%
– +1,211.5% +81.3% +159.8% -28.0% +62.5% +48.5% -28.3% -45.8%
– +1,333.8% +40.8% -40.7% +1.5% -34.8% +87.7% +12.6% -36.2%
– +1,333.8% +68.6% +169.4% -27.6% +65.1% +49.2% -28.0% -46.3%
– +100.0% +1,377.0% +26.8% -73.7% +27.5% -4.7% -23.2% -64.2%
– – – – – +0.0% – – –
– +130.8% -4.2% +5.9% +153.1% -59.0% – – –
– +2,014.5% +77.3% -89.6% +77.7% +68.2% +3.5% +140.7% -52.6%
– +59.5% +60.7% +41.9% +45.1% +42.1% +19.3% +16.5% -50.7%
– – – – – +31.5% -46.4% -58.9% +167.0%
– +61.6% -51.5% +61.8% +46.9% -46.8% +186.8% +31.5% -91.9%
– – – – – – +1.3% +200.5% –
– -126.4% – – -29.7% +57.4% +51.1% -35.8% -40.4%
– – – – – – – – –
– +1,954.8% +115.3% +0.0% +0.8% +17.2% +39.8% +3.1% +1.4%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?